Translation of the Frailty Paradigm from Older Adults to Children with Cardiac Disease

Chaitanya Panchangam, David A White, Suma Goudar, Brian Birnbaum, Lindsey Malloy-Walton, Jami Gross-Toalson, Kimberly J Reid, Girish Shirali, Anitha Parthiban, Chaitanya Panchangam, David A White, Suma Goudar, Brian Birnbaum, Lindsey Malloy-Walton, Jami Gross-Toalson, Kimberly J Reid, Girish Shirali, Anitha Parthiban

Abstract

Children and adolescents with cardiac disease (CCD) have significant morbidity and lower quality of life. However, there are no broadly applicable tools similar to the frailty score as described in the elderly, to define functional phenotype in terms of physical capability and psychosocial wellbeing in CCD. The purpose of this study is to investigate the domains of the frailty in CCD. We prospectively recruited CCD (8-17.5 years old, 70% single ventricle, 27% heart failure, 12% pulmonary hypertension; NYHA classes I, II and III) and age and gender matched healthy controls (total n = 56; CCD n = 34, controls n = 22; age 12.6 ± 2.6 years; 39.3% female). We measured the five domains of frailty: slowness, weakness, exhaustion, body composition and physical activity using developmentally appropriate methods. Age and gender-based population norms were used to obtain Z scores and percentiles for each measurement. Two-tailed t-tests were used to compare the two groups. The CCD group performed significantly worse in all five domains of frailty compared to healthy controls. Slowness: 6-min walk test with Z score -3.9 ± 1.3 vs -1.4 ± 1.3, p < 0.001; weakness: handgrip strength percentile 18.9 ± 20.9 vs 57.9 ± 26.0, p < 0.001; exhaustion: multidimensional fatigue scale percentile 63.7 ± 13.5 vs 83.3 ± 14.4, p < 0.001; body composition: height percentile 43.4 ± 29.5 vs 71.4 ± 25.2, p < 0.001, weight percentile 46.0 ± 36.0 vs 70.9 ± 24.3, p = 0.006, BMI percentile 48.4 ± 35.5 vs 66.9 ± 24.2, p = 0.04, triceps skinfold thickness 41.0 ± 24.0 vs 54.4 ± 22.1, p = 0.04; physical activity: pediatric activity questionnaire score 2 ± 0.6 vs 2.7 ± 0.6, p < 0.001. The domains of frailty can be quantified in children using developmentally appropriate methods. CCD differ significantly from controls in all five domains, supporting the concept of quantifying the domains of frailty. Larger longitudinal studies are needed to study frailty in CCD and examine if it predicts adverse health outcomes.Clinical Trial Registration: The ClinicalTrials.gov identification number is NCT02999438. https://ichgcp.net/clinical-trials-registry/NCT02999438.

Keywords: Cardiomyopathy; Children with heart disease; Congenital heart disease; Fontan; Frailty; Heart failure; Pulmonary hypertension; Quality and outcomes.

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Frailty domains by group with CCD group categorized by NYHA class. (A): Slowness - 6 minute walk test (6MWT) z-score; (B): Weakness - Hand grip strength percentile; (C): Exhaustion - Multidimensional Fatigue scale score; (D): Shrinkage/Body composition - Triceps skinfold thickness percentile; (E): Diminished physical activity - Pediatric activity questionnaire (PAQ) score. NYHA – New York Heart Association heart failure classification. NS = Not significant, * = p < 0.05, ** = p < 0.01

References

    1. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA, CHSCR Group Frailty in older adults: evidence for a phenotype. J Gerontol A. 2001;56:M146–M156.
    1. Shamliyan T, Talley KMC, Ramakrishnan R, Kane RL. Association of frailty with survival: a systematic literature review. Ageing Res Rev. 2013;12:719–736.
    1. Murali-Krishnan R, Iqbal J, Rowe R, Hatem E, Parviz Y, Richardson J, Sultan A, Gunn J. Impact of frailty on outcomes after percutaneous coronary intervention: a prospective cohort study. Open Heart. 2015;2:e000294.
    1. Lee DH, Buth KJ, Martin B-J, Yip AM, Hirsch GM. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation. 2010;121:973–978.
    1. Ness KK, Krull KR, Jones KE, Mulrooney DA, Armstrong GT, Green DM, Chemaitilly W, Smith WA, Wilson CL, Sklar CA, Shelton K, Srivastava DK, Ali S, Robison LL, Hudson MM. Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. J Clin Oncol. 2013;31:4496–4503.
    1. Lurz E, Quammie C, Englesbe M, Alonso EM, Lin HC, Hsu EK, Furuya KN, Gupta NA, Venkat VL, Daniel JF, Leonis MA, Miloh T, Telega GW, Yap J, Menendez J, Book LS, Himes RW, Sundaram SS, Parekh R, Sonnenday C, Bucuvalas J, Ng VL, Kamath BM. Frailty in children with liver disease: a prospective multicenter study. J Pediatr. 2018;194:109–115.e104.
    1. Paridon SM, Mitchell PD, Colan SD, Williams RV, Blaufox A, Li JS, Margossian R, Mital S, Russell J, Rhodes J, PHN Investigators A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol. 2008;52:99–107.
    1. Fraisse A, Jais X, Schleich J-M, di Filippo S, Maragnès P, Beghetti M, Gressin V, Voisin M, Dauphin C, Clerson P, Godart F, Bonnet D. Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. Arch Cardiovasc Dis. 2010;103:66–74.
    1. 9Sugimoto A, Ota N, Ibuki K, Miyakoshi C, Murata M, Tosaka Y, Yamazaki T, Sakamoto K (2013) Risk factors for adverse neurocognitive outcomes in school-aged patients after the Fontan operation. Eur J Cardiothorac Surg Off J Eur Assoc Cardiothorac Surg 44:454–461; discussion 461
    1. Nandi D, Rossano JW. Epidemiology and cost of heart failure in children. Cardiol Young. 2015;25:1460–1468.
    1. Shafazand S, Goldstein MK, Doyle RL, Hlatky MA, Gould MK. Health-related quality of life in patients with pulmonary arterial hypertension. Chest. 2004;126:1452–1459.
    1. Uzark K, Zak V, Shrader P, McCrindle BW, Radojewski E, Varni JW, Daniels K, Handisides J, Hill KD, Lambert LM, Margossian R, Pemberton VL, Lai WW, Atz AM, PHN Investigators Assessment of quality of life in young patients with single ventricle after the Fontan operation. J Pediatr. 2016;170:166–172.e161.
    1. den Boer SL, Baart SJ, van der Meulen MH, van Iperen GG, Backx AP, Ten Harkel AD, Rammeloo LA, du Marchie Sarvaas GJ, Tanke RB, Helbing WA, Utens EM, Dalinghaus M. Parent reports of health-related quality of life and heart failure severity score independently predict outcome in children with dilated cardiomyopathy. Cardiol Young. 2017;27(6):1–9.
    1. Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fischer V, Geiger H, Loeckinger A, Stein JI. Six-minute walk test in children and adolescents. J Pediatr. 2007;150(395–399):399.e391–392.
    1. Bohannon RW, Wang YC, Bubela D, Gershon RC. Handgrip strength: a population-based study of norms and age trajectories for 3- to 17-year-olds. Pediatr Phys Ther. 2017;29:118–123.
    1. Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW. PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity. Pediatr Blood Cancer. 2014;61:171–177.
    1. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer. 2002;94:2090–2106.
    1. Varni JW, Burwinkle TM, Szer IS. The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity. J Rheumatol. 2004;31:2494–2500.
    1. Varni JW, Limbers CA, Bryant WP, Wilson DP. The PedsQL Multidimensional Fatigue Scale in type 1 diabetes: feasibility, reliability, and validity. Pediatr Diabetes. 2009;10:321–328.
    1. Varni JW, Limbers CA, Bryant WP, Wilson DP. The PedsQL Multidimensional Fatigue scale in pediatric obesity: feasibility, reliability and validity. Int J Pediatr Obes. 2010;5:34–42.
    1. Kobayashi K, Okano Y, Hohashi N. Reliability and validity of the PedsQL™ Multidimensional Fatigue Scale in Japan. Qual Life Res. 2011;20:1091–1102.
    1. Centers of Disease Control . Healthy weight: assessing your weight: BMI for children and teens. Atlanta: CDC; 2011.
    1. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL (2000) CDC growth charts: United States. Adv Data (314):1–27
    1. McDowell MA, Fryar CD, Hirsch R, Ogden CL (2005) Anthropometric reference data for children and adults: U.S. population, 1999–2002. Adv Data (361):1–5
    1. Kowalski KC, Crocker PR, Faulkner RA. Validation of the physical activity questionnaire for older children. Pediatr Exerc Sci. 1997;9:174–186.
    1. Kowalski KC, Crocker PR, Kowalski NP. Convergent validity of the physical activity questionnaire for adolescents. Pediatr Exerc Sci. 1997;9:342–352.
    1. Kowalski KC, Crocker PRE; Donen RM (2004) The Physical Activity Questionnaire for older children (PAQ-C) and adolescents (PAQ-A) manual.
    1. Aaron D, Kriska A, Dearwater S, Cauley J, Metz K, LaPorte R. Reproducibility and validity of an epidemiologic questionnaire to assess past year physical activity in adolescence. Am J Epidemiol. 1995;142:191–201.
    1. Kriska AM, Knowler WC, LaPorte RE, Drash AL, Wing RR, Blair SN, Bennett PH, Kuller LH. Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care. 1990;13:401–411.
    1. Evenson KR, Catellier DJ, Gill K, Ondrak KS, McMurray RG. Calibration of two objective measures of physical activity for children. J Sports Sci. 2008;26:1557–1565.
    1. Hsu DT, Pearson GD. Heart failure in children: Part I: history, etiology, and pathophysiology. Circ Heart Fail. 2009;2:63–70.
    1. Frank DB, Crystal MA, Morales DLS, Gerald K, Hanna BD, Mallory GB, Rossano JW. Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000–2009. Pulm Circ. 2015;5:339–348.
    1. Faraoni D, Nasr VG, DiNardo JA. Overall hospital cost estimates in children with congenital heart disease: analysis of the 2012 Kid’s Inpatient Database. Pediatr Cardiol. 2016;37:37–43.
    1. d’Udekem Y, Iyengar AJ, Galati JC, Forsdick V, Weintraub RG, Wheaton GR, Bullock A, Justo RN, Grigg LE, Sholler GF, Hope S, Radford DJ, Gentles TL, Celermajer DS, Winlaw DS. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation. 2014;130:S32–S38.
    1. Barst RJ, McGoon MD, Elliott CG, Foreman AJ, Miller DP, Ivy DD. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation. 2012;125:113–122.
    1. 36Griffiths ER, Kaza AK, Wyler von Ballmoos MC, Loyola H, Valente AM, Blume ED, del Nido P (2009) Evaluating failing Fontans for heart transplantation: predictors of death. Ann Thorac Surg 88:558–563; discussion 554–563
    1. Badagliacca R, Poscia R, Pezzuto B, Papa S, Nona A, Mancone M, Mezzapesa M, Nocioni M, Sciomer S, Valli G, Cedrone N, Fedele F, Vizza CD. Pulmonary arterial dilatation in pulmonary hypertension: prevalence and prognostic relevance. Cardiology. 2012;121:76–82.
    1. Bandorski D, Bogossian H, Stempfl J, Seeger W, Hecker M, Ghofrani A, Hoeltgen R, Gall H. Prognostic relevance of nonsustained ventricular tachycardia in patients with pulmonary hypertension. BioMed Res Int. 2016;2016:1327265.
    1. Stepnowska E, Lewicka E, Dabrowska-Kugacka A, Danilowicz-Szymanowicz L, Zagozdzon P, Kaminski R, Lewicka-Potocka Z, Miekus P, Kozlowski D, Potocki W, Raczak G. Predictors of poor outcome in patients with pulmonary arterial hypertension: a single center study. PLoS ONE. 2018;13:e0193245.
    1. Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66:564–574.
    1. Kutner NG, Zhang R. Frailty in dialysis-dependent patients with end-stage renal disease. JAMA Intern Med. 2013;173:78–79.
    1. Runner RP, Bellamy JL, Vu CCL, Erens GA, Schenker ML, Guild GN., III Modified frailty index is an effective risk assessment tool in primary total knee arthroplasty. J Arthroplast. 2017;32:S177–S182.
    1. McIsaac DI, Moloo H, Bryson GL, van Walraven C. The association of frailty with outcomes and resource use after emergency general surgery: a population-based cohort study. Anesth Analg. 2017;124:1653–1661.
    1. Uchmanowicz I, Wleklik M, Gobbens RJJ. Frailty syndrome and self-care ability in elderly patients with heart failure. Clin Interv Aging. 2015;10:871–877.
    1. Mauthner O, Claes V, Deschodt M, Jha SR, Engberg S, Macdonald PS, Newton PJ, De Geest S. Handle with care: a systematic review on frailty in cardiac care and its usefulness in heart transplantation. Transplant Rev (Orlando) 2017;31:218–224.
    1. Voss C, Dean PH, Gardner RF, Duncombe SL, Harris KC. Validity and reliability of the Physical Activity Questionnaire for Children (PAQ-C) and Adolescents (PAQ-A) in individuals with congenital heart disease. PLoS ONE. 2017;12:e0175806.
    1. Cohen MS, Zak V, Atz AM, Printz BF, Pinto N, Lambert L, Pemberton V, Li JS, Margossian R, Dunbar-Masterson C, McCrindle BW. Anthropometric measures after Fontan procedure: implications for suboptimal functional outcome. Am Heart J. 2010;160(1092–1098):1098.e1091.
    1. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112:828–835.
    1. Ng TP, Feng L, Nyunt MS, Feng L, Niti M, Tan BY, Chan G, Khoo SA, Chan SM, Yap P, Yap KB. Nutritional, physical, cognitive, and combination interventions and frailty reversal among older adults: a randomized controlled trial. Am J Med. 2015;128:1225–1236.e1221.
    1. Monteserin R, Brotons C, Moral I, Altimir S, San Jose A, Santaeugenia S, Sellares J, Padros J. Effectiveness of a geriatric intervention in primary care: a randomized clinical trial. Fam Pract. 2010;27:239–245.
    1. Hedlund ER, Lundell B, Soderstrom L, Sjoberg G. Can endurance training improve physical capacity and quality of life in young Fontan patients? Cardiol Young. 2018;28:438–446.
    1. Cordina RL, O’Meagher S, Karmali A, Rae CL, Liess C, Kemp GJ, Puranik R, Singh N, Celermajer DS. Resistance training improves cardiac output, exercise capacity and tolerance to positive airway pressure in Fontan physiology. Int J Cardiol. 2013;168:780–788.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する